481 related articles for article (PubMed ID: 22734860)
1. Incidence of invasive squamous cell carcinomas in biopsy-proven squamous cell carcinomas in situ sent for Mohs micrographic surgery.
Chuang GS; Lu LK; Cummins DL; Wu H; Finn D; Rogers GS; Lee D
Dermatol Surg; 2012 Sep; 38(9):1456-60. PubMed ID: 22734860
[TBL] [Abstract][Full Text] [Related]
2. Squamous Cell Carcinoma In Situ Upstaged to Invasive Squamous Cell Carcinoma: A 5-Year, Single Institution Retrospective Review.
Eimpunth S; Goldenberg A; Hamman MS; Oganesyan G; Lee RA; Hunnangkul S; Song SS; Greywal T; Jiang SIB
Dermatol Surg; 2017 May; 43(5):698-703. PubMed ID: 28060173
[TBL] [Abstract][Full Text] [Related]
3. Squamous Cell Carcinoma in Situ Achieves Tumor Clearance in More Mohs Stages Than Invasive Squamous Cell Carcinoma.
Kim Y; Khan AH; Papachristou C; Decker A; Lawrence N
Dermatol Surg; 2023 Dec; 49(12):1104-1107. PubMed ID: 38019009
[TBL] [Abstract][Full Text] [Related]
4. Frequency of squamous cell carcinoma (SCC) invasion in transected SCC in situ referred for Mohs surgery: the Dartmouth-Hitchcock experience.
Knackstedt TJ; Brennick JB; Perry AE; Li Z; Quatrano NA; Samie FH
Int J Dermatol; 2015 Jul; 54(7):830-3. PubMed ID: 25920731
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of squamous cell carcinoma in situ of the ear treated using Mohs micrographic surgery.
Lee KC; Higgins HW; Lajevardi N; Cruz AP; Dufresne RG
Dermatol Surg; 2012 Dec; 38(12):1951-5. PubMed ID: 22989104
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic assessment of depth of follicular invasion of squamous cell carcinoma (SCC) in situ (SCCis): Implications for treatment approach.
Christensen SR; McNiff JM; Cool AJ; Aasi SZ; Hanlon AM; Leffell DJ
J Am Acad Dermatol; 2016 Feb; 74(2):356-62. PubMed ID: 26670714
[TBL] [Abstract][Full Text] [Related]
7. Residual skin cancer after preoperative biopsy: evaluation by Mohs micrographic surgery.
Alcalay J; Alkalay R; Hazaz B
Int J Dermatol; 2004 Jun; 43(6):456-8. PubMed ID: 15186232
[TBL] [Abstract][Full Text] [Related]
8. Rapid Evolution of a Squamous Cell Carcinoma In Situ to Locally Invasive With Perineural Involvement.
Juhasz M; Cohen JL
J Drugs Dermatol; 2020 Nov; 19(11):1110-1111. PubMed ID: 33196738
[TBL] [Abstract][Full Text] [Related]
9. Squamous Cell Carcinoma In Situ With Occult Invasion: A Tertiary Care Institutional Experience.
Newsom E; Connolly K; Phillips W; Lee E; Rossi A; Navarrete-Dechent C; Busam K; Dusza SW; Nehal K
Dermatol Surg; 2019 Nov; 45(11):1345-1352. PubMed ID: 30893175
[TBL] [Abstract][Full Text] [Related]
10. Assessing outcomes of topical 5-fluorouracil as primary and adjuvant therapy for squamous cell carcinoma in-situ.
Queen D; Trager MH; Fan W; Gordon ER; Samie FH
Arch Dermatol Res; 2024 May; 316(6):220. PubMed ID: 38787403
[TBL] [Abstract][Full Text] [Related]
11. Expression of gelatinases (MMP-2, MMP-9) and gelatinase activator (MMP-14) in actinic keratosis and in in situ and invasive squamous cell carcinoma.
Hernández-Pérez M; El-hajahmad M; Massaro J; Mahalingam M
Am J Dermatopathol; 2012 Oct; 34(7):723-8. PubMed ID: 22534634
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Squamous Cell Carcinoma
Muse M; Harris B; Dewey J; Saju S; Taylor A; Maxfield L; Cook C; Bermudez R
J Clin Aesthet Dermatol; 2023 Oct; 16(10):44-46. PubMed ID: 37915333
[TBL] [Abstract][Full Text] [Related]
13. Importance of vertical pathology of debulking specimens during Mohs micrographic surgery for lentigo maligna and melanoma in situ.
Iorizzo LJ; Chocron I; Lumbang W; Stasko T
Dermatol Surg; 2013 Mar; 39(3 Pt 1):365-71. PubMed ID: 23356872
[TBL] [Abstract][Full Text] [Related]
14. Squamous cell carcinoma in situ upstaging is not frequent in the nail unit: a tertiary cancer center experience.
Aleissa S; Cowen E; Navarrete-Dechent C; Busam KJ; Rossi AM; Lee EH; Nehal KS
Arch Dermatol Res; 2022 Jan; 314(1):89-93. PubMed ID: 32886149
[TBL] [Abstract][Full Text] [Related]
15. Telepathology in Mohs micrographic surgery.
Lambert DR; Peters SB
J Drugs Dermatol; 2008 May; 7(5):471-3. PubMed ID: 18505141
[TBL] [Abstract][Full Text] [Related]
16. Clinical value of paraffin sections in association with Mohs micrographic surgery for nonmelanoma skin cancers.
Ebede TL; Lee EH; Dusza SW; Busam KJ; Nehal KS
Dermatol Surg; 2012 Oct; 38(10):1631-8. PubMed ID: 22958072
[TBL] [Abstract][Full Text] [Related]
17. Incidence of residual basal cell carcinoma in patients who appear tumor free after biopsy.
Holmkvist KA; Rogers GS; Dahl PR
J Am Acad Dermatol; 1999 Oct; 41(4):600-5. PubMed ID: 10495384
[TBL] [Abstract][Full Text] [Related]
18. [Clinico-histologic characteristics of spinocellular carcinoma of the skin].
Stojanović S; Poljacki M; Vucković N; Tasić S
Med Pregl; 1998; 51(1-2):61-7. PubMed ID: 9531777
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia II. Perineural invasion.
Leibovitch I; Huilgol SC; Selva D; Hill D; Richards S; Paver R
J Am Acad Dermatol; 2005 Aug; 53(2):261-6. PubMed ID: 16021121
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Hill D; Richards S; Paver R
J Am Acad Dermatol; 2005 Aug; 53(2):253-60. PubMed ID: 16021120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
